Campbell Alex R, Satran Daniel, Zenovich Andrey G, Campbell Kayla M, Espel Julia C, Arndt Theresa L, Poulose Anil K, Boisjolie Charlene R, Juusola Kim, Bart Bradley A, Henry Timothy D
Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, MN 55407, USA.
Am Heart J. 2008 Dec;156(6):1217-22. doi: 10.1016/j.ahj.2008.07.024. Epub 2008 Oct 5.
BACKGROUND: Enhanced external counterpulsation (EECP) is a noninvasive treatment of patients with refractory angina. The immediate hemodynamic effects of EECP are similar to intra-aortic balloon pump counterpulsation, but EECP's effects on standard blood pressure measurements during and after treatment are unknown. METHODS: We evaluated systolic blood pressure (SBP) and diastolic blood pressure (DBP) for 108 consecutive patients undergoing EECP. Baseline SBP, DBP, and heart rate were compared for each patient before and after each EECP session, at the end of the course of EECP, and 6 weeks after the final EECP session. RESULTS: One hundred eight patients (mean age 66.4 +/- 11.2 years, 81% male) completed 36.5 +/- 5.1 EECP sessions per patient. Overall, based on 3,586 individual readings, EECP resulted in a decrease in mean SBP of 1.1 +/- 15.3 mm Hg at the end of each EECP session (P < .001), 6.4 +/- 18.2 mm Hg at the end the course of EECP (P < .001), and 3.7 +/- 17.8 mm Hg 6 weeks after the final EECP session (P = .07), with no significant change in DBP or heart rate. Stratifying by baseline SBP, a differential response was demonstrated: SBP increased in the 2 lowest strata (<100 mm Hg and 101-110 mm Hg) and decreased in the remaining strata (P < .001). Stratified differences were sustained after individual EECP sessions, at the end of the course of EECP, and 6 weeks after the final EECP session and were independent of changes in cardiovascular medications. CONCLUSIONS: Enhanced external counterpulsation improved SBP in patients with refractory angina. On average, EECP decreased SBP during treatment and follow-up; but for patients with low baseline SBP (<110 mm Hg), EECP increased SBP. The improvements in SBP may contribute to the clinical benefit of EECP.
背景:增强型体外反搏(EECP)是一种用于治疗顽固性心绞痛患者的非侵入性治疗方法。EECP的即时血流动力学效应与主动脉内球囊反搏相似,但EECP对治疗期间及治疗后标准血压测量值的影响尚不清楚。 方法:我们对连续108例接受EECP治疗的患者的收缩压(SBP)和舒张压(DBP)进行了评估。比较了每位患者在每次EECP治疗前、治疗后、EECP疗程结束时以及最后一次EECP治疗后6周时的基线SBP、DBP和心率。 结果:108例患者(平均年龄66.4±11.2岁,81%为男性)每人完成了36.5±5.1次EECP治疗。总体而言,基于3586次个体读数,每次EECP治疗结束时平均SBP下降1.1±15.3 mmHg(P <.001),EECP疗程结束时下降6.4±18.2 mmHg(P <.001),最后一次EECP治疗后6周下降3.7±17.8 mmHg(P =.07),DBP和心率无显著变化。按基线SBP分层,显示出不同的反应:最低的两个分层(<100 mmHg和101 - 110 mmHg)中SBP升高,其余分层中SBP下降(P <.001)。分层差异在每次EECP治疗后、EECP疗程结束时以及最后一次EECP治疗后6周均持续存在,且与心血管药物的变化无关。 结论:增强型体外反搏改善了顽固性心绞痛患者的SBP。平均而言,EECP在治疗和随访期间降低了SBP;但对于基线SBP较低(<110 mmHg)的患者,EECP升高了SBP。SBP的改善可能有助于EECP的临床益处。
Cardiovasc Revasc Med. 2007
Eur J Clin Invest. 2004-6
Interv Cardiol Clin. 2022-7
Clin Med Res. 2013-12
Nat Rev Cardiol. 2013-12-24
Clin Cardiol. 2012-8-9